Noliterax 10+2,5 mg filmovertrukne tabletter Danemark - danois - Lægemiddelstyrelsen (Danish Medicines Agency)

noliterax 10+2,5 mg filmovertrukne tabletter

les laboratoires servier - indapamid (vandfri), perindoprilarginin - filmovertrukne tabletter - 10+2,5 mg

Paraterax 8+2,5 mg tabletter Danemark - danois - Lægemiddelstyrelsen (Danish Medicines Agency)

paraterax 8+2,5 mg tabletter

les laboratoires servier - indapamid (vandfri), perindopril tert-butylamin - tabletter - 8+2,5 mg

Viacoram 3,5+2,5 mg tabletter Danemark - danois - Lægemiddelstyrelsen (Danish Medicines Agency)

viacoram 3,5+2,5 mg tabletter

les laboratoires servier - amlodipin, perindoprilarginin - tabletter - 3,5+2,5 mg

Valdoxan Union européenne - danois - EMA (European Medicines Agency)

valdoxan

les laboratoires servier - agomelatin - depressiv lidelse, major

Thymanax Union européenne - danois - EMA (European Medicines Agency)

thymanax

les laboratoires servier - agomelatin - depressiv lidelse, major

Libroxar 2+0,5 mg resoribletter, sublinguale Danemark - danois - Lægemiddelstyrelsen (Danish Medicines Agency)

libroxar 2+0,5 mg resoribletter, sublinguale

laboratoires smb s.a. - buprenorphinhydrochlorid, naloxonhydrochloriddihydrat - resoribletter, sublinguale - 2+0,5 mg

Libroxar 8+2 mg resoribletter, sublinguale Danemark - danois - Lægemiddelstyrelsen (Danish Medicines Agency)

libroxar 8+2 mg resoribletter, sublinguale

laboratoires smb s.a. - buprenorphinhydrochlorid, naloxonhydrochloriddihydrat - resoribletter, sublinguale - 8+2 mg

Tibsovo Union européenne - danois - EMA (European Medicines Agency)

tibsovo

les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antineoplastiske midler - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.

Monoprost 50 mikrogram/ml øjendråber, opløsning, enkeltdosisbeholder Danemark - danois - Lægemiddelstyrelsen (Danish Medicines Agency)

monoprost 50 mikrogram/ml øjendråber, opløsning, enkeltdosisbeholder

paranova danmark a/s - latanoprost - øjendråber, opløsning, enkeltdosisbeholder - 50 mikrogram/ml

Monoprost 50 mikrogram/ml øjendråber, opløsning, enkeltdosisbeholder Danemark - danois - Lægemiddelstyrelsen (Danish Medicines Agency)

monoprost 50 mikrogram/ml øjendråber, opløsning, enkeltdosisbeholder

2care4 aps - latanoprost - øjendråber, opløsning, enkeltdosisbeholder - 50 mikrogram/ml